当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析 - 现金流量表

前沿生物-U

(688221)

  

流通市值:83.27亿  总市值:83.27亿
流通股本:3.75亿   总股本:3.75亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金327,999,458.11112,281,305.4682,793,398.9151,351,668.55
  收到其他与经营活动有关的现金879,609.887,410,314.696,197,729.925,224,719.41
  经营活动现金流入小计328,879,067.99119,691,620.1588,991,128.8356,576,387.96
  购买商品、接受劳务支付的现金10,273,270.2147,258,975.425,612,230.2714,801,676.93
  支付给职工以及为职工支付的现金35,522,873.18105,886,150.7780,771,678.157,156,170.53
  支付的各项税费893,005.93,215,140.462,381,331.421,575,699.89
  支付其他与经营活动有关的现金64,310,129.44189,919,656.29132,015,477.6481,270,682.3
  经营活动现金流出小计110,999,278.73346,279,922.92240,780,717.43154,804,229.65
  经营活动产生的现金流量净额217,879,789.26-226,588,302.77-151,789,588.6-98,227,841.69
二、投资活动产生的现金流量:
  取得投资收益收到的现金4,040,837.2712,222,334.5110,209,145.797,184,561.17
  处置固定资产、无形资产和其他长期资产收回的现金净额30034,00028,00028,000
  处置子公司及其他营业单位收到的现金净额-27,473,375.3415,128,712.3315,128,712.33
  收到的其他与投资活动有关的现金647,700,0002,973,387,512.332,453,828,1001,534,298,100
  投资活动现金流入小计651,741,137.273,013,117,222.182,479,193,958.121,556,639,373.5
  购建固定资产、无形资产和其他长期资产支付的现金2,214,541.0529,864,170.7826,075,665.3123,669,991.96
  支付其他与投资活动有关的现金910,066,4002,810,570,0002,397,670,0001,442,550,000
  投资活动现金流出小计912,280,941.052,840,434,170.782,423,745,665.311,466,219,991.96
  投资活动产生的现金流量净额-260,539,803.78172,683,051.455,448,292.8190,419,381.54
三、筹资活动产生的现金流量:
  取得借款收到的现金142,258,756.4361,850,023.44289,559,879.25216,774,000
  筹资活动现金流入小计142,258,756.4361,850,023.44289,559,879.25216,774,000
  偿还债务支付的现金78,017,800362,623,796.37323,472,535.62289,433,314.37
  分配股利、利润或偿付利息支付的现金1,973,748.418,193,704.96,303,490.884,520,884.01
  支付其他与筹资活动有关的现金2,289,91215,455,43315,000,000-
  筹资活动现金流出小计82,281,460.41386,272,934.27344,776,026.5293,954,198.38
  筹资活动产生的现金流量净额59,977,295.99-24,422,910.83-55,216,147.25-77,180,198.38
四、汇率变动对现金及现金等价物的影响-60,241.86-47,436.25-26,046.19-15,167.51
五、现金及现金等价物净增加额17,257,039.61-78,375,598.45-151,583,489.23-85,003,826.04
  加:期初现金及现金等价物余额170,344,359.37248,719,957.82248,719,957.82248,719,957.82
  期末现金及现金等价物余额187,601,398.98170,344,359.3797,136,468.59163,716,131.78
补充资料:
  净利润--268,053,032.03--97,352,610.68
  资产减值准备-2,866,584.85-89,923.13
  固定资产和投资性房地产折旧-20,709,667.09-9,121,391.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-20,709,667.09-9,121,391.86
  无形资产摊销-21,616,253.3-10,998,831.51
  长期待摊费用摊销-589,964.8-299,227.67
  处置固定资产、无形资产和其他长期资产的损失-26,728.07--15,353.93
  固定资产报废损失-1,806.06--
  公允价值变动损失-546,697.65-297,011.44
  财务费用-8,625,645.13-3,796,838.12
  投资损失-1,062,974.77-1,861,944.89
  存货的减少--19,113,212.28--13,804,530.31
  经营性应收项目的减少--27,872,292.61--1,825,792.17
  经营性应付项目的增加-5,831,261.21--13,385,260.26
  其他-3,595,045.86--
  现金的期末余额-170,344,359.37-163,716,131.78
  减:现金的期初余额-248,719,957.82-248,719,957.82
  现金及现金等价物的净增加额--78,375,598.45--85,003,826.04
公告日期2026-04-252026-04-252025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑